AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

Covered by 2 sourcesPublished 4 hours ago

AstraZeneca has entered a deal with AI drug discovery firm Insitro, paying $40 million upfront and potentially up to $1.5 billion if milestones are met, to advance AI-driven therapeutics.

Covered by 2 sources

The Wall Street Journal
ET AI (The Economic Times)

#astrazeneca #drug-discovery #insitro

AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

Covered by 2 sources

More in Healthcare

Accelerating the search for antimicrobial peptides with Google Antigravity

AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro

Patients' frustration at GP surgery's AI receptionist